| Code | CSB-RA008541MB2HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is developed as a research-grade biosimilar to BI-1607, targeting FCGR2B (Fc gamma receptor IIB, also known as CD32B). FCGR2B is an inhibitory Fc receptor expressed predominantly on B cells, dendritic cells, and myeloid cells, playing a crucial role in regulating immune responses by transmitting inhibitory signals upon binding to IgG immune complexes. This receptor functions as a negative regulator of B cell activation and antibody production, helping to maintain immune homeostasis and prevent autoimmunity. Dysregulation of FCGR2B has been implicated in various autoimmune disorders including systemic lupus erythematosus, rheumatoid arthritis, and other inflammatory conditions, as well as in cancer immune evasion mechanisms.
The reference antibody BI-1607 has been utilized in immunological research to investigate FCGR2B expression patterns, receptor function, and its role in immune regulation. This biosimilar provides researchers with a reliable tool for studying inhibitory Fc receptor signaling pathways, B cell biology, and immune checkpoint mechanisms in various experimental models.
There are currently no reviews for this product.